In vitro, IRP2 knockdown in prostate cancer cell lines reduces intracellular iron, inhibiting cell cycle progression by inducing cell cycle inhibitors, as well as triggering apoptosis. The gene discussed is IREB2; the disease is prostate carcinoma.